Litcius/Paper detail

COVID-19 and the Interplay With Antibacterial Drug Resistance

Laxmi Kant Bhardwaj, Prangya Rath, Shubhansh Bajpai, Divya Upadhyay, Harshita Jain, Naresh Kumar, Shivani Sinha

2024Advances in medical diagnosis, treatment, and care (AMDTC) book series10 citationsDOI

Abstract

Antimicrobial resistance (AMR) is a growing public health issue worldwide that affects the world economy. The concern associated with this issue increased during the COVID-19 pandemic. The misuse of antibiotics during the COVID-19 pandemic will have catastrophic implications for the control of AMR. In 2019, the coronavirus illness COVID-19 first appeared in China. COVID-19 infection is a surface-to-surface communicable disease. It is considered the most vital global health disaster of the century. It has rapidly spread around the world and is the greatest challenge for humankind. This chapter discusses the origin, symptoms, transmission, treatment, and recommendations of the COVID-19 disease.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Multi drug resistantVirologyDrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDrug resistanceMedicinePharmacologyBiologyInfectious disease (medical specialty)MicrobiologyInternal medicineOutbreakDiseaseAntibiotic Use and ResistanceCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research